OncoSolutions

OncoSolutions is a biotechnology and healthcare startup that is headquartered in Cork, Ireland. Founded in 2017, the company has developed a groundbreaking technology called CyCa-dds, a molecular nanomachine designed for precise drug delivery and cell labeling. This unique platform has caught the attention of investors, with the most recent Convertible Note investment occurring on 31 July 2019. The investment was led by SOSV and RebelBio.

The innovative approach of CyCa OncoSolutions has significant potential in revolutionizing the way cancer-fighting medication is administered. By providing targeted and scheduled delivery of drugs, the technology is a promising development in the healthcare industry. The ability to accurately label living cells further demonstrates the versatility and impact of CyCa-dds.

With its base in Ireland, OncoSolutions stands at the forefront of biotechnology, offering a pioneering solution that has attracted interest from notable investors. As the company continues to advance its technology and expand its reach, it represents an exciting prospect for venture capitalists seeking opportunities in the biotech and healthcare sectors. The recent investment marks a significant milestone and underscores the confidence of investors in OncoSolutions' potential for growth and innovation.